June 2018 - Volume 28 - Issue 3
pp: 171-257


Basic research


Translational research


Early evolution of BRAFV600 status in the blood of melanoma patients correlates with clinical outcome and identifies patients refractory to therapy

Gonzalez-Cao, Maria; Mayo de las Casas, Clara; Jordana Ariza, Nuria; More

Melanoma Research. 28(3):195-203, June 2018.

Clinical research


Lymph node ratio as a prognostic factor in melanoma: results from European Organization for Research and Treatment of Cancer 18871, 18952, and 18991 studies

Testori, Alessandro A.; Suciu, Stefan; van Akkooi, Alexander C.J.; More

Melanoma Research. 28(3):222-229, June 2018.

Sarcoid-like reactions in patients receiving modern melanoma treatment

Dimitriou, Florentia; Frauchiger, Anna L.; Urosevic-Maiwald, Mirjana; More

Melanoma Research. 28(3):230-236, June 2018.


Potential clinical and immunotherapeutic utility of talimogene laherparepvec for patients with melanoma after disease progression on immune checkpoint inhibitors and BRAF inhibitors

Chesney, Jason; Imbert-Fernandez, Yoannis; Telang, Sucheta; More

Melanoma Research. 28(3):250-255, June 2018.